Month: December 2020

FRANKFURT/MAIN, Dec. 09, 2020 (GLOBE NEWSWIRE) — Die neue Realität des Geschäftslebens im Zeitalter von COVID-19 lässt mehr und mehr deutsche Unternehmen auf die Cloud setzen. Dadurch steigen für Amazon Web Services (AWS) und ihre Partner die Chancen, diese Unternehmen auf ihrem Weg zu mehr Flexibilität und Effizienz zu unterstützen. Dies meldet eine neue, heute veröffentlichte Studie der Information Services Group (ISG) (Nasdaq: III). ISG ist ein führendes, globales Marktforschungs- und Beratungsunternehmen im Technologie-Segment.Der „ISG Provider Lens™ AWS Ecosystem Partners Report Germany 2020“ stellt fest, dass die Pandemie zu Herausforderungen geführt hat, für deren Bewältigung cloudbasierte Ressourcen und Anwendungen besonders gut geeignet sind. Mit dem Auftreten von Lockdowns und Störungen in den Geschäftsabläufen seit Anfang...

HOUSTON, Dec. 09, 2020 (GLOBE NEWSWIRE) — Cardtronics plc (“Cardtronics” or the “Company”) (Nasdaq: CATM) today confirmed that it has received a proposal from funds managed by affiliates of Apollo Global Management, Inc. and Hudson Executive Capital LP to acquire all of the outstanding shares of the Company for $31.00 per share in cash.Given his role as Founder & Managing Partner of Hudson Executive Capital LP, Douglas Braunstein has recused himself from any discussions that the Cardtronics Board of Directors has had regarding any transaction. The other members of the Cardtronics Board of Directors will review and assess the terms of the proposal.No specific timetable has been set and there can be no assurances that the review of this proposal will result in the consummation of any agreement or transaction. The Company does...

Webcast heute, Montag, den 7. Dezember,16:00 Uhr MEZ / 10:00 Uhr ETDie Studie bestätigt das Potenzial von Eryaspase als attraktive Behandlungsoption für ALL-Patienten mit Überempfindlichkeit gegenüber PEG-AsparaginaseLYON, Frankreich und CAMBRIDGE, Mass., Dec. 09, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq und Euronext: ERYP), ein biopharmazeutisches Unternehmen im Bereich der klinischen Forschung, das innovative Therapien entwickelt, bei denen Arzneimittelwirkstoffe in roten Blutkörperchen eingekapselt werden, gibt heute die Ergebnisse der von der NOPHO gesponserten Phase-II-Studie von Eryaspase bei Patienten mit akuter lymphoblastischer Leukämie (ALL) bekannt, die gestern von Dr. Line Stensig Lynggaard auf der 62. Jahrestagung der American Society of Hematology (ASH) präsentiert wurden. In dem heute stattfindenden Webcast...

Il webcast è programmato per oggi, lunedì 7 dicembre,alle ore 16:00 CET/10:00 ETLo studio conferma il potenziale di eryaspase come opzione terapeutica interessante per i pazienti affetti da leucemia linfoblastica acuta (LLA) con ipersensibilità all’asparaginasi pegilata.LIONE, Francia e CAMBRIDGE, Mass., Dec. 09, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), un’azienda biofarmaceutica che svolge studi clinici e sviluppa terapie innovative con l’incapsulamento di principi attivi terapeutici nei globuli rossi, ha annunciato oggi i risultati dello studio di Fase II sponsorizzato da NOPHO di eryaspase in pazienti affetti da LLA, presentati ieri dalla Dott.ssa Line Stensig Lynggaard in occasione del 62oconvegno annuale dell’American Society of Hematology (ASH). Durante il webcast trasmesso oggi,...

Regnskabstallene nedenfor er foreløbige og kan blive ændret frem mod offentliggørelse af årsregnskabsmeddelelse og årsrapport den 11. marts 2021.Ved offentliggørelsen af delårsrapporten for 3. kvartal 2020, meddelte selskabet, at der kunne forventes et resultat af primær drift før værdireguleringer i niveauet 23 mio. kr. Denne forventning er uændret.Selskabet har i de seneste måneder konstateret en større efterspørgsel efter den type ejendomme som indgår i selskabets portefølje. Specielt vedrørende lager- og logistikejendommene ses en positiv udvikling i såvel efterspørgsel fra potentielle lejere som i markedsleje, hvilket selskabet opfatter som en konsekvens af den stigende online handel i forbindelse med corona krisen. Ligeledes ses en tendens fra investorer, til i endnu højere grad at efterspørge lager– og logistikejendomme, hvilket...

WALL, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics will present at the LD Micro Virtual Main Event 2020 Investor Conference on Tuesday, December 15th. BIO-key’s Chairman and CEO Mike DePasquale will give an introduction and address questions from an investor panel, beginning at 3:20pm ET and ending at 3:40pm ET.The LD Micro Virtual Main Event conference takes place December 14th and 15th and will feature over 200 small / micro-cap companies.To learn more or to register for the Main Event please visit: https://ve.mysequire.com/Chris Lahiji, Founder of LD, commented, “This year’s Main Event features a unique format that will make it the first virtual conference this year that is engaging instead of repetitive....

GAITHERSBURG, Md., Dec. 09, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Margaret G. McGlynn, R. Ph. to its board as an independent director. Ms. McGlynn brings extensive pharmaceutical industry, vaccine and non-profit experience to her role on the Novavax Board of Directors.“Margie’s deep experience in vaccine commercialization and understanding of global public health will be invaluable as we move closer to collecting Phase 3 clinical data and submitting NVX-CoV2373, our COVID-19 vaccine candidate, for regulatory authorization and approval,” said Stanley C. Erck, Novavax President and Chief Executive Officer.Ms. McGlynn is currently President and Board Chair for HCU Network America,...

HAMPTON, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that the first patient has been dosed in its open label clinical trial in cold contact urticaria and symptomatic dermographism, the two most common forms of chronic inducible urticaria (CIndU). CDX-0159 is a humanized monoclonal antibody developed by Celldex that binds the KIT receptor with high specificity and potently inhibits its activity. The KIT receptor tyrosine kinase is expressed in a variety of cells, including mast cells, which mediate inflammatory responses such as hypersensitivity and allergic reactions. KIT signaling controls the differentiation, tissue recruitment, survival and activity of mast cells. As previously presented, CDX-0159 demonstrated a favorable safety profile as well as profound and durable reductions...

BEVERLY, Mass., Dec. 09, 2020 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce that Dr. Jack Regan, LexaGene’s CEO and Founder, will present at the 13th Annual LD Micro Main Event Conference, on December 15, 2020, at 9:00 a.m. (Eastern Time).Interested parties can register to attend at the following link: https://ve.mysequire.com/In addition, the Company is pleased to announce that it has engaged Native Ads, Inc., of New York, New York to perform strategic digital media services, marketing and data analytics services including, but not limited to, content development, video production and editing, website development, media buying and distribution, and campaign reporting and...

VANCOUVER, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to announce the results of a recently completed surface geochemical sampling and reconnaissance mapping program at the Mercedes Target, which is located 3km to the north of the Company’s flagship Marimaca Oxide Deposit (“MOD”).HighlightsGeochemical sampling has identified a large copper anomaly with grades as high as 0.6% in surface samplingCentral geochemical high is approximately 300 metres by 300 metres and is coincident with historical mine workings with grades ranging from 0.2% up to 0.6% copperA large plus 200ppm Cu anomaly extends over an area of approximately 600 metres by 500 metres, which compares favorably to the MODApproximately half of the Mercedes Target is concealed by post...